About: Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: an example of the need of validation studies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: an example of the need of validation studies Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: an example of the need of validation studies
Creator	Cruz, Marilyn Angel, Miguel Castillo, Paulina Freire-Paspuel, Byron Garcia-Bereguiain, Miguel Vega-Mariño, Patricio Velez, Alberto Ma, Garcia-Bereguiain
topic	covid:e0851c20d5fde0c204d20198de16e07700ee82a0#this
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: Several qPCR kits are available for SARS-CoV-2 diagnosis, mostly lacking of evaluation due to covid19 emergency. OBJECTIVE: We evaluated nCoV-QS (MiCo BioMed) kit using CDC kit as gold standard. RESULTS: We found limitations for nCoV-QS: 1) lower sensitivity 2) lack of RNA quality control probe. CONCLUSIONS: Validation studies should be implemented for any SARS-CoV-2 RT-qPCR commercial kit to prevent unreliable diagnosis.
has issue date	2020-05-22(xsd:dateTime)
bibo:doi	10.1016/j.jcv.2020.104454
bibo:pmid	32485473
has license	no-cc
sha1sum (hex)	e0851c20d5fde0c204d20198de16e07700ee82a0
schema:url	https://doi.org/10.1016/j.jcv.2020.104454
resource representing a document's title	Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: an example of the need of validation studies
has PubMed Central identifier	PMC7243755
has PubMed identifier	32485473
schema:publication	J Clin Virol
resource representing a document's body	covid:e0851c20d5fde0c204d20198de16e07700ee82a0#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/e0851c20d5fde0c204d20198de16e07700ee82a0
is schema:about of	named entity 'RT-qPCR' named entity 'Evaluation' named entity 'validation' named entity 'Evaluation' named entity 'SARS-CoV-2' named entity 'FDA' named entity 'CONCLUSIONS' named entity 'USING' named entity 'EXAMPLE' named entity 'PROBE' named entity 'NCOV' named entity 'CDC' named entity 'SARS-CoV-2' named entity 'RNA' named entity 'qPCR' named entity 'qPCR' named entity 'RNA' named entity 'CDC' named entity 'gold standard' named entity 'FDA' named entity 'gold standard' named entity 'SARS-CoV-2' named entity 'RT-qPCR' named entity 'gold standard' named entity 'nasopharyngeal' named entity 'nasopharyngeal' named entity 'RT-qPCR' named entity 'FDA' named entity 'CDC' named entity 'viral load' named entity 'SARS-CoV-2' named entity 'nasopharyngeal swabs' named entity 'RNase P' named entity 'positive control' named entity 'CDC' named entity 'RT-qPCR' named entity '2019-nCoV' named entity 'quality control' named entity 'nCoV' named entity 'RNA extraction' named entity 'emergency use authorization' named entity 'SARS-CoV-2' named entity 'Covid19' named entity 'EUA' named entity 'SARS-CoV-2' named entity 'CDC' named entity 'assay' named entity 'EUA' named entity 'RNA extraction' named entity 'CDC' named entity 'positive controls' named entity 'EUA' named entity 'qPCR' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'FDA' named entity 'EUA' named entity 'FDA' named entity 'Ecuador' named entity 'patient care' named entity 'SARS-CoV' named entity 'viral load' named entity 'EUA' named entity 'pH 8' named entity 'nCoV' named entity '2019-nCoV' named entity 'assay' named entity 'CDC' named entity 'Puerto Ayora' named entity 'quality control' named entity 'developing countries' named entity 'EUA'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software